Emerging Players in Qatar Pancreatitis Market | Competitive Landscape 2026

Qatar Pancreatitis Market Overview

According to 6Wresearch, the Qatar pancreatitis market is steadily expanding, driven by rising metabolic health issues and a high prevalence of gallstone-related cases in the region. The industry is also boosted by the recent introduction of robotic pancreatic surgery at Hamad Medical Corporation, which has significantly decreased the need for patients to fly overseas for specialized care.

Furthermore, the expansion of private specialized institutions, such as The View Hospital and Naseem Medical Centre, has increased the availability of endoscopic ultrasound (EUS) and personalized nutritional therapies.

Competitive Landscape

The competitive landscape in Qatar is a strategic blend of high-capacity public health providers and specialized private hospital groups, with global pharmaceutical companies supplying crucial digestive enzymes and anti-inflammatory medications. Success in this market is defined by clinical excellence in critical care and a robust supply chain that bridges global pharmacology with local surgical expertise.

Below is a list of leading players operating in the Qatar Pancreatitis Market:

1. Hamad Medical Corporation (HMC)

The primary provider of pancreatic care in Qatar, HMC recently performed the nation's first robotic Whipple surgery and manages the majority of acute cases through its General Surgery and GI departments.

2. Abbott

A critical market leader, Abbott supplies Creon, the gold-standard pancreatic enzyme replacement therapy (PERT) used for chronic pancreatitis management across Qatar.

3. Ebn Sina Medical

Qatar's largest distributor, managing the supply of specialized GI medications and enzymes from international manufacturers to HMC and retail pharmacies.

4. The View Hospital

A premium private hospital recognized for world-class gastroenterology and hepatology services, utilizing advanced 3D imaging for complex pancreatic diagnostics.

5. Viatris Inc.

Supplies high-volume off-patent medications used in the supportive treatment of pancreatitis, including analgesics and metabolic regulators.

6. Naseem Medical Centre

A prominent private provider offering specialized gastroenterology clinics focused on the diagnosis and long-term management of chronic pancreatic insufficiency.

7. Al Jazira Medical Group

A leading provider of integrated healthcare services and medical supplies, supporting the infrastructure of Qatar's surgical and diagnostic departments.

8. Ibn Al-Haytham Medical Co.

A subsidiary of Mohammad Bin Hamad Holding, specializing in the distribution of high-end medical equipment for abdominal surgery and diagnostics.

9. Nestlé Health Science

Supplies specialized nutritional support and elemental diets essential for patients recovering from severe acute pancreatitis.

10. Hikma Pharmaceuticals PLC

A major regional supplier of anti-infectives and analgesics used in the standardized management protocols for pancreatic infections.

11. Sandoz

Provides high-quality generic alternatives for supportive therapies, aiding in the cost-effective management of chronic pancreatitis complications.

12. Teva Pharmaceutical Industries Ltd.

Supplies the Qatari market with various supportive medications, including proton pump inhibitors (PPIs) used to manage acidity in pancreatitis patients.